Committee Action
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 6829. The title of the hearing was
``Legislative Proposals to Support Patients and Caregivers.''
The Subcommittee received testimony from:
Andy Shih, PhD, Chief Science Officer,
Autism Speaks;
Corey Feist, JD, MBA, Co-Founder and CEO,
Dr. Lorna Breen Heroes' Foundation;
Joanne Pike, DrPH, President and CEO,
Alzheimer's Association;
Gordon Tomaselli, MD, Former President,
American Heart Association; Marilyn and Stanley M. Katz
Dean, Emeritus and Professor of Medicine, Albert
Einstein College of Medicine; Adjunct Professor of
Medicine, Johns Hopkins University School of Medicine;
Michelle Whitten, President, CEO, and Co-
Founder, Global Down Syndrome Foundation;
Randy Strozyk, President, American Ambulance
Association; and
Christina Annunziata, MD, PhD, Senior Vice
President of Extramural Discovery Science, American
Cancer Society.
On March 12, 2024, the Subcommittee on Health met in open
markup session and forwarded H.R. 6829, as amended, to the full
Committee by a record vote of 24 yeas and 0 nays.
On March 20, 2024, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 6829, as
amended, favorably reported to the House by a record vote of 42
yeas and 0 nays.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to prevent
deaths from cardiac arrest by providing information and
resources that prepare schools to respond in the event of a
cardiac emergency.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 6829 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII, the following
related hearing was used to develop or consider H.R. 6829:
On February 14, 2024, the Subcommittee on
Health held a hearing on H.R. 6829. The title of the
hearing was ``Legislative Proposals to Support Patients
and Caregivers.'' The Subcommittee received testimony
from:
Andy Shih, PhD, Chief Science
Officer, Autism Speaks;
Corey Feist, JD, MBA, Co-Founder
and CEO, Dr. Lorna Breen Heroes' Foundation;
Joanne Pike, DrPH, President and
CEO, Alzheimer's Association;
Gordon Tomaselli, MD, Former
President, American Heart Association; Marilyn
and Stanley M. Katz Dean, Emeritus and
Professor of Medicine, Albert Einstein College
of Medicine; Adjunct Professor of Medicine,
Johns Hopkins University School of Medicine;
Michelle Whitten, President,
CEO, and Co-Founder, Global Down Syndrome
Foundation;
Randy Strozyk, President,
American Ambulance Association; and
Christina Annunziata, MD, PhD,
Senior Vice President of Extramural Discovery
Science, American Cancer Society.
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 6829 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1. Short title
Section 1 provides that the Act may be cited as the
``Cardiomyopathy Health Education, Awareness, and Research, and
AED Training in the Schools Act of 2024'' or the ``HEARTS Act
of 2024''.
Section 2. Cardiomyopathy health education, awareness, and research,
and AED training in schools
Section 2 amends the Public Health Service Act to provide
organization for the Cardiomyopathy Education and Awareness
Program and authorizes this program through fiscal year 2029.
This section implements a timeline for the submission of
reports and the dissemination of educational materials. In
addition, this section also seeks to expand and coordinate
cardiomyopathy related research and establish a grant program
to promote student access to automated external defibrillators
(AEDs) and cardiopulmonary resuscitation (CPR).
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE
* * * * * * *
Part B--Federal-State Cooperation
* * * * * * *
SEC. 312. PUBLIC ACCESS DEFIBRILLATION PROGRAMS.
(a) In General.--The Secretary shall award grants to States,
political subdivisions of States, Indian tribes, and tribal
organizations to develop and implement public access
defibrillation programs--
(1) by training and equipping local emergency medical
services personnel, including firefighters, police
officers, paramedics, emergency medical technicians,
and other first responders, to administer immediate
care, including cardiopulmonary resuscitation and
automated external defibrillation, to cardiac arrest
victims;
(2) by purchasing automated external defibrillators,
placing the defibrillators in public places where
cardiac arrests are likely to occur, and training
personnel in such places to administer cardiopulmonary
resuscitation and automated external defibrillation to
cardiac arrest victims;
(3) by setting procedures for proper maintenance and
testing of such devices, according to the guidelines of
the manufacturers of the devices;
(4) by providing training to members of the public in
cardiopulmonary resuscitation and automated external
defibrillation;
(5) by integrating the emergency medical services
system with the public access defibrillation programs
so that emergency medical services personnel, including
dispatchers, are informed about the location of
automated external defibrillators in their community;
and
(6) by encouraging private companies, including small
businesses, to purchase automated external
defibrillators and provide training for their employees
to administer cardiopulmonary resuscitation and
external automated defibrillation to cardiac arrest
victims in their community.
(b) Preference.--In awarding grants under subsection (a), the
Secretary shall give a preference to a State, political
subdivision of a State, Indian tribe, or tribal organization
that--
(1) has a particularly low local survival rate for
cardiac arrests, or a particularly low local response
rate for cardiac arrest victims; or
(2) demonstrates in its application the greatest
commitment to establishing and maintaining a public
access defibrillation program.
(c) Use of Funds.--A State, political subdivision of a State,
Indian tribe, or tribal organization that receives a grant
under subsection (a) may use funds received through such grant
to--
(1) purchase automated external defibrillators that
have been approved, or cleared for marketing, by the
Food and Drug Administration;
(2) provide automated external defibrillation and
basic life support training in automated external
defibrillator usage through nationally recognized
courses;
(3) provide information to community members about
the public access defibrillation program to be funded
with the grant;
(4) provide information to the local emergency
medical services system regarding the placement of
automated external defibrillators in public places;
(5) produce materials to encourage private companies,
including small businesses, to purchase automated
external defibrillators;
(6) establish an information clearinghouse, that
shall be administered by an organization that has
substantial expertise in pediatric education, pediatric
medicine, and electrophysiology and sudden death, that
provides information to increase public access to
defibrillation in schools; and
(7) further develop strategies to improve access to
automated external defibrillators in public places.
(d) Application.--
(1) In general.--To be eligible to receive a grant
under subsection (a), a State, political subdivision of
a State, Indian tribe, or tribal organization shall
prepare and submit an application to the Secretary at
such time, in such manner, and containing such
information as the Secretary may reasonably require.
(2) Contents.--An application submitted under
paragraph (1) shall--
(A) describe the comprehensive public access
defibrillation program to be funded with the
grant and demonstrate how such program would
make automated external defibrillation
accessible and available to cardiac arrest
victims in the community;
(B) contain procedures for implementing
appropriate nationally recognized training
courses in performing cardiopulmonary
resuscitation and the use of automated external
defibrillators;
(C) contain procedures for ensuring direct
involvement of a licensed medical professional
and coordination with the local emergency
medical services system in the oversight of
training and notification of incidents of the
use of the automated external defibrillators;
(D) contain procedures for proper maintenance
and testing of the automated external
defibrillators, according to the labeling of
the manufacturer;
(E) contain procedures for ensuring
notification of local emergency medical
services system personnel, including
dispatchers, of the location and type of
devices used in the public access
defibrillation program; and
(F) provide for the collection of data
regarding the effectiveness of the public
access defibrillation program to be funded with
the grant in affecting the out-of-hospital
cardiac arrest survival rate.
(e) Authorization of Appropriations.--[For the purpose of
carrying out this section, there are authorized to be
appropriated $25,000,000 for for each of fiscal years 2003
through 2014.] For the purpose of carrying out this section and
sections 312A, 312B, 312C, and 312D, there is authorized to be
appropriated $25,000,000 for each of fiscal years 2025 through
2029. Not more than 10 percent of amounts received under a
grant awarded under this section may be used for administrative
expenses.
SEC. 312A. MATERIALS AND RESOURCES TO INCREASE EDUCATION AND AWARENESS
OF CARDIOMYOPATHY AMONG SCHOOL ADMINISTRATORS,
EDUCATORS, AND FAMILIES.
(a) Materials and Resources.--Not later than 18 months after
the date of the enactment of the HEARTS Act of 2024, the
Secretary, in consultation with the Director of the Centers for
Disease Control and Prevention, shall develop public education
materials and resources to be disseminated to school
administrators, educators, school health professionals,
coaches, families, guardians, caregivers, and other appropriate
individuals. The materials and resources shall include--
(1) information on the signs, symptoms, and risk
factors associated with high-risk cardiac conditions
and genetic heart rhythm abnormalities that may cause
sudden cardiac arrest in children, adolescents, and
young adults, including--
(A) cardiomyopathy;
(B) long QT syndrome, Brugada syndrome,
catecholaminergic polymorphic ventricular
tachycardia, short QT syndrome, and Wolff-
Parkinson-White syndrome; and
(C) other high-risk cardiac conditions, as
determined by the Secretary;
(2) guidelines regarding the placement of automated
external defibrillators in schools, early childhood
education programs, and child care centers;
(3) training information on automated external
defibrillators and cardiopulmonary resuscitation; and
(4) recommendations for how schools, early childhood
education programs, and child care centers can develop
and implement a cardiac emergency response plan.
(b) Dissemination of Materials and Resources.--Not later than
30 months after the date of the enactment of the HEARTS Act of
2024, the Secretary shall disseminate the materials and
resources developed under subsection (a) in accordance with the
following:
(1) Distribution by state educational agencies.--The
Secretary shall make available such materials and
resources to State educational agencies to distribute--
(A) to school administrators, educators,
school health professionals, coaches, families,
guardians, caregivers, and other appropriate
individuals, the information developed under
subsection (a)(1);
(B) to parents, guardians, or other
caregivers, the cardiomyopathy risk assessment
developed pursuant to section 312B(b)(1); and
(C) to school administrators, educators,
school health professionals, and coaches--
(i) the guidelines described in
subsection (a)(2);
(ii) the training information
described in subsection (a)(3); and
(iii) the recommendations described
in subsection (a)(4).
(2) Dissemination to health departments and
professionals.--The Secretary shall make available the
materials and resources developed under subsection (a)
to State and local health departments, pediatricians,
hospitals, and other health professionals, such as
nurses and first responders.
(3) Posting on website.--
(A) CDC.--
(i) In general.--The Secretary,
through the Director, shall post the
materials and resources developed under
subsection (a) on the public Internet
website of the Centers for Disease
Control and Prevention.
(ii) Additional information.--The
Director is encouraged to maintain on
such public Internet website such
additional information regarding
cardiomyopathy as deemed appropriate by
the Director.
(B) State educational agencies.--State
educational agencies are encouraged to create
public Internet webpages dedicated to
cardiomyopathy and post the materials and
resources developed under subsection (a) on
such webpages.
(c) Definitions.--In this section:
(1) The term ``cardiomyopathy'' means a heart disease
that affects the heart's muscle (myocardium)--
(A) the symptoms of which may vary from case
to case, including--
(i) cases in which no symptoms are
present (asymptomatic); and
(ii) cases in which there are
symptoms of a progressive condition
that may result from an impaired
ability of the heart to pump blood,
such as fatigue, irregular heartbeats
(arrhythmia), heart failure, and,
potentially, sudden cardiac death; and
(B) the recognized types of which include
dilated, hypertrophic, restrictive,
arrhythmogenic right ventricular dysplasia, and
left ventricular non-compaction.
(2) The term ``Director'' means the Director of the
Centers for Disease Control and Prevention.
(3) The terms ``early childhood education program'',
``elementary school'', and ``secondary school'' have
the meanings given to those terms in section 8101 of
the Elementary and Secondary Education Act of 1965.
(4) The term ``school administrator'' means a
principal, director, manager, or other supervisor or
leader within an elementary school, secondary school,
State-based early childhood education program, or child
care center.
(5) The term ``school health professional'' means a
health professional serving at an elementary school,
secondary school, State-based early childhood education
program, or child care center.
SEC. 312B. ACTIVITIES RELATING TO CARDIOMYOPATHY.
(a) Report on CDC National Cardiomyopathy Activities.--
(1) In general.--Not later than 18 months after the
date of the enactment of the HEARTS Act of 2024, the
Secretary, acting through the Director of the Centers
for Disease Control and Prevention, shall submit to
Congress a report on findings generated from existing
activities conducted by the Centers for Disease Control
and Prevention to improve the understanding of the
prevalence and epidemiology of cardiomyopathy across
the lifespan, from birth to adulthood, with particular
interest in the following:
(A) The natural history of individuals with
cardiomyopathy, in both the pediatric and adult
population.
(B) Estimates of cardiomyopathy-related
emergency department visits and
hospitalizations, in both the pediatric and
adult population.
(2) Public access.--Subject to paragraph (3), the
report submitted under this subsection shall be made
available to the public.
(3) Privacy p